New Drug For Muscular Dystrophy Promises Benefit Without Risk Of Infection
A new drug being studied for the treatment of muscle degenerating diseases has shown promising results. According to a study published in the British Journal of Pharmacology, Debio 025 is as effective as current drugs but, crucially, does not cause unwanted immunosuppressive effects. Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy (UCMD) are muscle wasting diseases caused by deficiencies in collagen VI, a component of connective tissue.
More: continued here
Filed under: Muscular Dystrophy on June 25th, 2009
You must be logged in to post a comment.